Cargando…

Ferroportin disease: pathogenesis, diagnosis and treatment

Ferroportin Disease (FD) is an autosomal dominant hereditary iron loading disorder associated with heterozygote mutations of the ferroportin-1 (FPN) gene. It represents one of the commonest causes of genetic hyperferritinemia, regardless of ethnicity. FPN1 transfers iron from the intestine, macropha...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pietrangelo, Antonello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709096/ https://www.ncbi.nlm.nih.gov/pubmed/29101207 http://dx.doi.org/10.3324/haematol.2017.170720

Ejemplares similares

Human macrophage ferroportin biology and the basis for the ferroportin disease
por: Sabelli, Manuela, et al.
Publicado: (2017)

Ferroportin disease: A systematic meta-analysis of clinical and molecular findings()
por: Mayr, Roman, et al.
Publicado: (2010)

Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
por: Nemeth, Elizabeta
Publicado: (2010)

Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

Corrigendum to “Ferroportin disease: A systematic meta-analysis of clinical and molecular findings” J. Hepatol. 2010 Nov;53(5):941–949
por: Mayr, Roman, et al.
Publicado: (2011)

Pediatric Ferroportin Disease
por: Galicia-Poblet, Gonzalo, et al.
Publicado: (2016)

Ferroportin and Erythroid Cells: An Update
por: Cianetti, Luciano, et al.
Publicado: (2010)

A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages
por: Ekaputri, Stella, et al.
Publicado: (2022)

A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation)
por: Bayele, Henry K., et al.
Publicado: (2021)

Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
por: Hawula, Zachary J., et al.
Publicado: (2019)

Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin
por: Gammella, Elena, et al.
Publicado: (2021)

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
por: Nemeth, Elizabeta, et al.
Publicado: (2021)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

Pharmacological Targeting of the Hepcidin/Ferroportin Axis
por: Sebastiani, Giada, et al.
Publicado: (2016)

Decreased expression of ferroportin in prostate cancer
por: Xue, Dong, et al.
Publicado: (2021)

Isolation and thermal stabilization of mouse ferroportin
por: Deshpande, Chandrika N., et al.
Publicado: (2020)

Mechanism of Ca(2+) transport by ferroportin
por: Shen, Jiemin, et al.
Publicado: (2023)

Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
por: Kowdley, Devan S, et al.
Publicado: (2021)

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
por: Pogribny, Igor P
Publicado: (2010)

Structural basis of ion transport and inhibition in ferroportin
por: Pan, Yaping, et al.
Publicado: (2020)

The Role of Copper in the Regulation of Ferroportin Expression in Macrophages
por: Jończy, Aneta, et al.
Publicado: (2021)

Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives
por: Marcacci, Matteo, et al.
Publicado: (2022)

Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
por: Bao, Wen-Dai, et al.
Publicado: (2021)

Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
por: Shibabaw, Tewodros, et al.
Publicado: (2020)

UBA6 and NDFIP1 regulate the degradation of ferroportin
por: Traeger, Lisa, et al.
Publicado: (2021)

Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features
por: Vlasveld, L. Tom, et al.
Publicado: (2019)

Structural basis of ferroportin inhibition by minihepcidin PR73
por: Wilbon, Azaan Saalim, et al.
Publicado: (2023)

Hepcidin induces HIV-1 transcription inhibited by ferroportin
por: Xu, Min, et al.
Publicado: (2010)

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

Structures of ferroportin in complex with its specific inhibitor vamifeport
por: Lehmann, Elena Farah, et al.
Publicado: (2023)

Calcium is an essential cofactor for metal efflux by the ferroportin transporter family
por: Deshpande, Chandrika N., et al.
Publicado: (2018)

Macrophage ferroportin is essential for stromal cell proliferation in wound healing
por: Recalcati, Stefania, et al.
Publicado: (2019)

Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
por: Billesbølle, Christian B., et al.
Publicado: (2020)

Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases
por: Aheget, Houssam, et al.
Publicado: (2020)

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease
por: Raha, Animesh Alexander, et al.
Publicado: (2013)

Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C
por: Ma, Lanqing, et al.
Publicado: (2014)

Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease
por: Jiang, Liqun, et al.
Publicado: (2019)

Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment
por: Kinoshita, Yoshikazu, et al.
Publicado: (2021)

Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
por: Ross, Sandra L., et al.
Publicado: (2017)

Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: LIAO, JUN, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pg44msoeeqqjmi6rkeicvn99kq